scholarly journals Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults

2016 ◽  
Vol 47 ◽  
pp. 185-195 ◽  
Author(s):  
Diane R. Gold ◽  
Augusto A. Litonjua ◽  
Vincent J. Carey ◽  
JoAnn E. Manson ◽  
Julie E. Buring ◽  
...  
Keyword(s):  
Vitamin D ◽  
Fatty Acid ◽  
Lung Function ◽  
Asthma Control ◽  
Chronic Respiratory Disease ◽  
Omega 3 ◽  
Omega 3 Fatty Acid ◽  
Ancillary Study ◽  
Acute Exacerbations ◽  
Baseline Characteristics

scholarly journals The Effects of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients: A Pilot Study

Marine Drugs ◽  
2015 ◽  
Vol 13 (2) ◽  
pp. 741-755 ◽  
Author(s):  
Su Lee ◽  
Young Son ◽  
Seong Kim ◽  
Won An
Keyword(s):  
Vitamin D ◽  
Fatty Acid ◽  
Pilot Study ◽  
Hemodialysis Patients ◽  
Omega 3 ◽  
Omega 3 Fatty Acid

scholarly journals Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes

JAMA ◽  
2019 ◽  
Vol 322 (19) ◽  
pp. 1899 ◽  
Author(s):  
Ian H. de Boer ◽  
Leila R. Zelnick ◽  
John Ruzinski ◽  
Georgina Friedenberg ◽  
Julie Duszlak ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin D ◽  
Fatty Acid ◽  
Kidney Function ◽  
Omega 3 ◽  
Fatty Acid Supplementation ◽  
Acid Supplementation ◽  
Omega 3 Fatty Acid

SP350Modulating hepcidin levels by vitamin D and omega-3 fatty acid in 5/6 nephrectomy rat model

2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
sumi lee ◽  
Nam Hyun Kyung ◽  
Son Young Ki ◽  
Kim Seong Eun ◽  
An Won Suk
Keyword(s):  
Vitamin D ◽  
Fatty Acid ◽  
Rat Model ◽  
Omega 3 ◽  
Omega 3 Fatty Acid

Abstract TP433: Effect of Vitamin D and Marine Omega-3 Fatty Acid Supplements on Stroke Outcomes

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Pamela M Rist ◽  
Nancy R Cook ◽  
JoAnn E Manson ◽  
Julie E Buring ◽  
Kathryn M Rexrode
Keyword(s):  
Vitamin D ◽  
Fatty Acid ◽  
Physical Disability ◽  
Functional Limitations ◽  
Functional Health ◽  
Older Individuals ◽  
Omega 3 ◽  
Stroke Outcomes ◽  
Omega 3 Fatty Acid ◽  
Low Serum

Introduction: Low serum 25-hydroxyvitamin D (25(OH)D) and low marine omega-3 fatty acid (n-3) intake are associated with increased stroke risk in observational studies. Among stroke patients, low serum 25(OH)D at admission predicts poor outcomes and animal studies suggest that higher n-3 intake may diminish brain damage in ischemic stroke. However, few studies have examined effects of vitamin D or n-3 supplements on stroke outcomes. Hypothesis: We hypothesized that vitamin D (cholecalciferol, 2,000 IU/day) or n-3 (840 mg/day of EPA/DHA [ratio of 1.3:1]) supplementation initiated prior to stroke would reduce risk of functional limitations or physical disability after stroke compared to placebo. Methods: We used data from the completed VITamin D and OmegA-3 TriaL (VITAL) which randomized 25,871 men aged ≥50 years and women aged ≥55 years without cardiovascular disease or cancer at baseline and followed them for incident events over 5.3 years. Individuals experiencing a stroke were mailed a questionnaire to assess functional limitations (with the physical performance scale adapted from Nagi) and physical disability (with the modified Katz Activities of Daily Living and Rosow-Breslau Functional Health scales). We used logistic regression to analyze associations between randomized treatment assignments and limitations on each scale. Results: 290 individuals experienced their first stroke during the trial (including 42 fatal strokes). 197 stroke survivors completed the stroke outcomes questionnaire a mean of 1.6 years after diagnosis. We observed no associations between randomized treatment to vitamin D and functional limitations (odds ratio (OR)=1.01, 95% confidence interval (CI): 0.52, 1.97) or physical disability on the Rosow-Breslau (OR=1.03, 95% CI: 0.31, 3.42) or Katz (OR=0.92, 95% CI: 0.50, 1.67) scales. Although not statistically significant, those randomized to n-3 had lower risk of functional limitations (OR=0.55, 95% CI: 0.28, 1.09) and physical disability on the Katz scale (OR=0.32, 95% CI: 0.50, 1.67) but not on the Rosow-Breslau scale (OR=1.03, 95% CI: 0.31, 3.42). Conclusion: Supplementation with vitamin D or omega-3 fatty acids prior to stroke did not result in significantly improved outcomes after stroke among older individuals.

The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes

2017 ◽  
Vol 11 (2) ◽  
pp. 459-468 ◽  
Author(s):  
Mehri Jamilian ◽  
Mansooreh Samimi ◽  
Faraneh Afshar Ebrahimi ◽  
Teibeh Hashemi ◽  
Mohsen Taghizadeh ◽  
...  
Keyword(s):  
Vitamin D ◽  
Fatty Acid ◽  
Glycemic Control ◽  
Gestational Diabetes ◽  
Omega 3 ◽  
Omega 3 Fatty Acid
Sign in / Sign up

Export Citation Format

Share Document